Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axsome Thera
(NQ:
AXSM
)
86.59
-4.59 (-5.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Thera
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
Meta Platforms Layoffs 2023: What to Know as Facebook Preps More Job Cuts
February 13, 2023
Meta Platforms (META) layoffs are a hot topic among traders Monday as the Facebook parent company reportedly considering more job cuts.
Via
InvestorPlace
Axsome Therapeutics (AXSM) Stock Falls as Teva Pursues Generic Depression Drug
February 13, 2023
Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug.
Via
InvestorPlace
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
February 13, 2023
The company only just gained approval for its depression drug in August.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
February 12, 2023
These companies could grow in prominence in the coming years.
Via
The Motley Fool
The Latest Analyst Ratings for Axsome Therapeutics
January 30, 2023
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $1,900 Today
January 09, 2023
Via
Benzinga
Here's How Much $100 Invested In Axsome Therapeutics 5 Years Ago Would Be Worth Today
December 23, 2022
Via
Benzinga
3 Surefire Growth Stocks You Can Buy Right Now
February 11, 2023
Maybe there's no such thing as a sure thing. But these stocks could come close.
Via
The Motley Fool
3 Stocks That Could Soar Whether There's a New Bull Market or Not
February 10, 2023
These stocks could enjoy their own bull markets regardless of what the overall market does.
Via
The Motley Fool
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
January 31, 2023
Axsome to host conference call and webcast on Monday, Feb. 27, 2023, at 8:00 a.m. ET
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
The Ultimate Growth Stocks to Buy With $300 Right Now
January 29, 2023
These three companies should deliver inflation-busting long-term growth.
Via
The Motley Fool
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
These stocks have plenty of room to run.
Via
The Motley Fool
3 Unstoppable Stocks to Keep Buying in 2023
January 19, 2023
These companies have what it takes to drive long-term share performance.
Via
The Motley Fool
2 Stocks That Could Double Your Money in 2023
January 07, 2023
These biotechs could crush the market, but there is more to the story.
Via
The Motley Fool
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.
January 07, 2023
These stocks look cheap if you take a long-term view.
Via
The Motley Fool
5 Top Stocks to Buy to Start the New Year Right
January 05, 2023
This may be the easiest of your New Year's resolutions. And it could pay off big.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
How Is The Market Feeling About Axsome Therapeutics?
January 03, 2023
Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 7.06% since its last report. The company recently reported that it has 7.37 million shares sold short, which is 20.81% of all...
Via
Benzinga
100 Best Stocks Of 2022: Fossil Fuel Ignites, Solar Shines, Meds Make Miracles
December 30, 2022
Energy and medical plays top the 100 Best Stocks of 2022. It makes sense, given world events that shifted the first-quarter playing field.
Via
Investor's Business Daily
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
These biotechs are far from having achieved their full potential.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
2 Top Biotech Stocks to Buy for the Long Haul
December 25, 2022
These mid-cap biotechs are solid long-term choices.
Via
The Motley Fool
Got $5,000? 2 Unstoppable Stocks to Buy and Hold
December 22, 2022
These businesses are growing and can be excellent places to make a sizable investment right now.
Via
The Motley Fool
Better Buy: Moderna vs Axsome
December 22, 2022
Revenue prospects look promising for both of these biotech companies.
Via
The Motley Fool
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
Should You Buy Stocks If a Recession Is Coming in 2023? Here's What History Shows.
December 17, 2022
Stocks usually go down during recessions, but long-term investors can still come out on top.
Via
The Motley Fool
After Jumping 100%, Is Axsome a Buy Before 2023?
December 16, 2022
Axsome's revenue story is just getting started.
Via
The Motley Fool
Is Anavex Life Sciences a Buy?
December 13, 2022
It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.